Powered by

Alliance for Cancer Gene Therapy Announces Kevin Honeycutt as CEO and President

Nov 01, 2018 - Business Wire
Board and Executive Moves

Alliance for Cancer Gene Therapy (ACGT) , the nation's only public charity exclusively funding cancer cell and gene therapy research, announced today that Kevin Honeycutt will be joining ACGT as its new CEO and President, effective December 3, 2018. Mr. Honeycutt was most recently the President and CEO of the Avon Breast Cancer Crusade (ABCC) since 2015. At ACGT, his principal role will be to enhance the vision of ACGT, begun in 2001 by its co-founders, Barbara Netter and her late husband Edward...